Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Debt to Equity (2016 - 2022)

Historic Debt to Equity for Fennec Pharmaceuticals (FENC) over the last 8 years, with Q3 2022 value amounting to $8.92.

  • Fennec Pharmaceuticals' Debt to Equity changed N/A to $8.92 in Q3 2022 from the same period last year, while for Sep 2022 it was $8.92, marking a year-over-year change of. This contributed to the annual value of $6.24 for FY2017, which is 6742013.92% up from last year.
  • Per Fennec Pharmaceuticals' latest filing, its Debt to Equity stood at $8.92 for Q3 2022.
  • In the past 5 years, Fennec Pharmaceuticals' Debt to Equity registered a high of $8.92 during Q3 2022, and its lowest value of $0.4 during Q1 2022.